Neurovascular Embolization Devices Market Industry Forecast Reflecting Growth To $1.91 Billion By 2030
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Neurovascular Embolization Devices Market Through 2030?
The neurovascular embolization devices market has experienced significant expansion in recent years. It is projected to grow from $1.38 billion in 2025 to $1.47 billion in 2026, at a compound annual growth rate (CAGR) of 6.2%. This historical growth can be attributed to factors such as the increasing prevalence of cerebral aneurysms, the expansion of neurointerventional procedures, the rising availability of skilled neurovascular specialists, growing hospital investments in advanced neurocare, and the wider adoption of minimally invasive stroke treatments.
The neurovascular embolization devices market size is anticipated to undergo significant expansion over the forthcoming years. It is projected to climb to $1.91 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.8%. This expansion during the forecast period stems from factors such as increasing demand for advanced stroke management solutions, rising investments in neurovascular research and development, the growing aging population afflicted with vascular disorders, wider adoption of next-generation embolization devices, and an enhanced focus on improving procedural outcomes. Noteworthy trends expected in this period include the increasing uptake of flow diversion stents, the growing utilization of liquid embolic systems, a rising preference for minimally invasive neurointerventions, the development of coil technologies with advanced coatings, and an intensified focus on precision neurovascular devices.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp
What Core Drivers Are Transforming The Neurovascular Embolization Devices Market?
An increasing occurrence of hemorrhages is anticipated to drive the growth of the neurovascular embolization devices market in the future. These are characterized by unusual, unmanageable bleeding, either internally within the body or externally via a disruption in the skin or mucous membrane. The widespread occurrence of hemorrhages stems from various elements, including an aging populace, a higher frequency of hypertension, and the broader application of anticoagulant drugs. In cases of hemorrhagic strokes, neurovascular embolization devices are employed to block atypical blood vessels, thereby minimizing blood loss and averting additional cerebral harm. For example, findings from King’s College London, a public research university located in the UK, revealed in February 2024 that both the incidence and fatalities resulting from intracerebral hemorrhage (ICH), a particular form of hemorrhage, are projected to rise by 59.4% among individuals aged 70 to 95 throughout the UK by the year 2050. Consequently, the increasing frequency of hemorrhages is a key factor propelling the expansion of the neurovascular embolization devices market.
Which Segment Divisions Form The Structure Of The Neurovascular Embolization Devices Market?
The neurovascular embolization devices market covered in this report is segmented –
1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Neurovascular Hemorrhage Management, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
2) By Liquid Embolic Systems: N-Butyl Cyanoacrylate-Based Embolics, Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips
5) By Other Products: Balloons For Embolization, Microcatheters
What Trends Are Influencing The Neurovascular Embolization Devices Market?
Leading companies active in the neurovascular embolization devices market are concentrating on developing advanced solutions, such as next-generation flow diverters, with the aim of replacing traditional approaches to aneurysm treatment. A next-generation flow diverter is characterized as a device that boosts procedural safety and effectiveness by improving vessel wall apposition, lowering the risk of clotting, and enabling easier deployment within complex aneurysm anatomies. For example, in July 2025, Stryker Corporation, a US-based medical technology company, launched the Surpass Elite Flow Diverter as an addition to its neurovascular portfolio. This innovation serves to supersede older aneurysm treatment devices by providing a minimally invasive flow diversion therapy for managing large or giant unruptured intracranial aneurysms. It delivers superior thrombo-resistance and an optimized braid design, allowing physicians to achieve better procedural outcomes with less manipulation. Integrated with Stryker’s training and physician support programs, it offers a seamless clinical experience. The Surpass Elite Flow Diverter enhances patient safety, streamlines procedural workflows, and helps expand the adoption of flow diversion therapy in neurovascular care.
Which Organizations Are Operating Within The Neurovascular Embolization Devices Market?
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH, Cerenovus, Sequent Medical Inc
Access The Complete Neurovascular Embolization Devices Market Report:
Which Region Leads The Neurovascular Embolization Devices Market By Size?
North America was the largest region in the neurovascular embolization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Neurovascular Embolization Devices Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Neurovascular Embolization Devices Market 2026, By The Business Research Company
Tumor Embolization Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Transcatheter Embolization And Occlusion Devices Market Report 2026
Vascular Embolization Market Report 2026
https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
